Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (5): 567-575.doi: 10.19982/j.issn.1000-6621.20260018
• Original Articles • Previous Articles Next Articles
Huang Guojun1,2, Wang Qiqi3, Zheng Wenjing4, Liu Jianjun5, Bai Liqiong6, Liang Jun6, Yu Shicheng3, Xu Zuhui7, Wan Yanping7, Liu Xie2, Yao Hongyan1(
), Ming Hui2(
)
Received:2026-01-10
Online:2026-05-10
Published:2026-04-27
Contact:
Yao Hongyan,Ming Hui
E-mail:yaohy@chinacdc.cn;17858654@qq.com
Supported by:CLC Number:
Huang Guojun, Wang Qiqi, Zheng Wenjing, Liu Jianjun, Bai Liqiong, Liang Jun, Yu Shicheng, Xu Zuhui, Wan Yanping, Liu Xie, Yao Hongyan, Ming Hui. Trend of pulmonary tuberculosis reported incidence in Hunan Province from 2009 to 2023: a population-based study using Joinpoint regression model[J]. Chinese Journal of Antituberculosis, 2026, 48(5): 567-575. doi: 10.19982/j.issn.1000-6621.20260018
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20260018
| 年份 | 全省 | 男性 | 女性 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 患者 例数 | 人口数 (×10万) | 粗发病率 (/10万) | 标化率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 粗发病率 (/10万) | 标化率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 粗发病率 (/10万) | 标化率 (/10万) | |
| 2009 | 60348 | 638.48 | 94.52 | 96.76 | 44307(73.42) | 330.94 | 133.88 | 139.75 | 16041(26.58) | 307.54 | 52.16 | 52.62 |
| 2010 | 57821 | 640.60 | 90.26 | 91.48 | 42430(73.38) | 331.80 | 127.88 | 131.90 | 15391(26.62) | 308.80 | 49.84 | 50.00 |
| 2011 | 57830 | 656.84 | 88.04 | 88.01 | 42597(73.66) | 337.75 | 126.12 | 127.86 | 15233(26.34) | 319.09 | 47.74 | 47.48 |
| 2012 | 60704 | 659.56 | 92.04 | 90.26 | 44365(73.08) | 339.07 | 130.84 | 129.28 | 16339(26.92) | 320.49 | 50.98 | 50.07 |
| 2013 | 59938 | 663.89 | 90.28 | 89.21 | 43361(72.34) | 341.57 | 126.95 | 125.89 | 16577(27.66) | 322.32 | 51.43 | 51.21 |
| 2014 | 58326 | 669.06 | 87.18 | 85.03 | 42299(72.52) | 345.15 | 122.55 | 119.83 | 16027(27.48) | 323.91 | 49.48 | 48.75 |
| 2015 | 56718 | 673.72 | 84.19 | 81.70 | 41035(72.35) | 345.54 | 118.76 | 115.78 | 15683(27.65) | 328.19 | 47.79 | 46.66 |
| 2016 | 51931 | 677.54 | 76.65 | 73.48 | 37531(72.27) | 349.22 | 107.47 | 103.24 | 14400(27.73) | 328.32 | 43.86 | 42.47 |
| 2017 | 52967 | 682.20 | 77.64 | 74.88 | 38254(72.22) | 347.31 | 110.14 | 106.31 | 14713(27.78) | 334.89 | 43.93 | 42.95 |
| 2018 | 55586 | 686.01 | 81.03 | 77.84 | 40205(72.33) | 353.48 | 113.74 | 109.03 | 15381(27.67) | 332.53 | 46.25 | 45.38 |
| 2019 | 56620 | 689.88 | 82.07 | 77.04 | 40633(71.76) | 355.83 | 114.19 | 107.17 | 15987(28.24) | 334.05 | 47.86 | 46.04 |
| 2020 | 52539 | 691.84 | 75.94 | 70.64 | 37573(71.51) | 357.10 | 105.22 | 97.69 | 14966(28.49) | 334.74 | 44.71 | 42.95 |
| 2021 | 49250 | 664.45 | 74.12 | 66.38 | 35340(71.76) | 339.96 | 103.95 | 92.58 | 13910(28.24) | 324.49 | 42.87 | 40.08 |
| 2022 | 43967 | 662.20 | 66.40 | 56.93 | 31445(71.52) | 339.20 | 92.70 | 79.01 | 12522(28.48) | 323.00 | 38.77 | 34.80 |
| 2023 | 44760 | 660.45 | 67.77 | 56.09 | 31894(71.26) | 338.00 | 94.36 | 77.91 | 12866(28.74) | 322.45 | 39.90 | 34.37 |
| 合计 | 819305 | 10016.72 | 81.79 | 77.97 | 593269(72.41) | 5151.91 | 115.16 | 110.88 | 226036(27.59) | 4864.80 | 46.46 | 45.06 |
| 分层 | 不同时间段 | 2009—2023年AAPC (%,95%CI) | P值 | ||
|---|---|---|---|---|---|
| 时间段 | APC(%,95%CI) | P值 | |||
| 全省 | 2009—2020年 | -2.58(3.43~-1.73) | <0.001 | -3.91(-5.21~-2.59) | <0.001 |
| 2020—2023年 | -8.61(-14.36~-2.48) | 0.011 | |||
| 男性 | 2009—2020年 | -2.95(-3.76~-2.13) | <0.001 | -4.19(-5.43~-2.92) | <0.001 |
| 2020—2023年 | -8.58(-14.11~-2.69) | 0.009 | |||
| 女性 | 2009—2020年 | -1.64(-2.62~-0.65) | 0.004 | -3.03(-4.54~-1.51) | <0.001 |
| 2020—2023年 | -7.97(-14.56~-0.87) | 0.032 | |||
| 年份 | 0~14岁 | 15~59岁 | 60岁及以上 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | |
| 2009 | 447(0.74) | 109.33 | 4.09 | 41211(68.29) | 449.88 | 91.61 | 18690(30.97) | 79.27 | 235.78 |
| 2010 | 348(0.60) | 112.01 | 3.11 | 38979(67.41) | 446.59 | 87.28 | 18494(31.98) | 82.00 | 225.53 |
| 2011 | 321(0.56) | 115.98 | 2.77 | 38709(66.94) | 449.15 | 86.18 | 18800(32.51) | 91.71 | 204.99 |
| 2012 | 286(0.47) | 117.68 | 2.43 | 38881(64.05) | 444.23 | 87.52 | 21537(35.48) | 97.64 | 220.57 |
| 2013 | 297(0.50) | 119.90 | 2.48 | 37976(63.36) | 444.55 | 85.42 | 21665(36.15) | 99.44 | 217.88 |
| 2014 | 285(0.49) | 122.35 | 2.33 | 35717(61.24) | 442.32 | 80.75 | 22323(38.27) | 104.39 | 213.84 |
| 2015 | 286(0.50) | 123.17 | 2.32 | 34023(59.99) | 446.45 | 76.21 | 22409(39.51) | 104.10 | 215.26 |
| 2016 | 285(0.55) | 123.03 | 2.32 | 31241(60.16) | 441.76 | 70.72 | 20405(39.29) | 112.75 | 180.98 |
| 2017 | 286(0.54) | 125.60 | 2.28 | 31190(58.89) | 443.83 | 70.27 | 21491(40.57) | 112.77 | 190.58 |
| 2018 | 457(0.82) | 126.28 | 3.62 | 32209(57.94) | 440.59 | 73.10 | 22920(41.23) | 119.14 | 192.38 |
| 2019 | 477(0.84) | 136.19 | 3.50 | 31221(55.14) | 424.76 | 73.50 | 24922(44.02) | 128.94 | 193.29 |
| 2020 | 503(0.96) | 136.73 | 3.68 | 29038(55.27) | 424.38 | 68.42 | 22998(43.77) | 130.72 | 175.93 |
| 2021 | 463(0.94) | 129.69 | 3.57 | 26478(53.76) | 402.64 | 65.76 | 22309(45.30) | 132.11 | 168.86 |
| 2022 | 372(0.85) | 125.32 | 2.97 | 22619(51.45) | 406.60 | 55.63 | 20976(47.71) | 130.28 | 161.01 |
| 2023 | 378(0.84) | 120.33 | 3.14 | 21392(47.79) | 405.12 | 52.80 | 22990(51.36) | 135.00 | 170.30 |
| 合计 | 5491(0.67) | 1843.59 | 2.98 | 490884(59.91) | 6512.87 | 75.37 | 322929(39.41) | 1660.26 | 194.51 |
| 年龄段 | 不同时间段 | 2009—2023年AAPC (%,95%CI) | P值 | ||
|---|---|---|---|---|---|
| 时间段 | APC(%,95%CI) | P值 | |||
| 0~14岁 | 2009—2011年 | -18.96(-25.20~-9.20) | <0.001 | -1.91(-3.17~-0.55) | 0.002 |
| 2011—2016年 | -3.46(-8.52~3.24) | 0.245 | |||
| 2016—2019年 | 19.50(9.90~25.45) | 0.003 | |||
| 2019—2023年 | -5.07(-13.15~-1.05) | 0.020 | |||
| 15~59岁 | 2009—2013年 | -1.20(-2.35~1.92) | 0.297 | -3.73(-4.11~-3.30) | <0.001 |
| 2013—2016年 | -6.27(-7.99~-4.23) | <0.001 | |||
| 2016—2019年 | 1.78(-0.96~3.66) | 0.173 | |||
| 2019—2023年 | -8.20(-10.44~-6.98) | <0.001 | |||
| ≥60岁 | 2009—2023年 | -2.42(-3.01~-1.82) | <0.001 | -2.42(-3.01~-1.82) | <0.001 |
| 年份 | 湘北地区 | 湘中地区 | 湘南地区 | 湘西地区 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | 患者数[例 (构成比,%)] | 人口数 (×10万) | 发病率 (/10万) | |
| 2009 | 13510(22.47) | 150.96 | 89.49 | 20987(34.91) | 232.79 | 90.16 | 16136(26.84) | 167.75 | 96.19 | 9490(15.78) | 86.97 | 109.11 |
| 2010 | 12938(22.39) | 151.39 | 85.46 | 20839(36.07) | 233.73 | 89.16 | 15142(26.21) | 168.65 | 89.78 | 8858(15.33) | 86.82 | 102.02 |
| 2011 | 13170(22.79) | 155.08 | 84.92 | 20970(36.29) | 245.06 | 85.57 | 14907(25.80) | 169.03 | 88.19 | 8742(15.13) | 87.66 | 99.72 |
| 2012 | 13582(22.39) | 155.32 | 87.44 | 21987(36.24) | 246.36 | 89.25 | 15953(26.30) | 169.84 | 93.93 | 9147(15.08) | 88.04 | 103.90 |
| 2013 | 13553(22.61) | 155.96 | 86.90 | 21482(35.84) | 248.67 | 86.39 | 15710(26.21) | 170.71 | 92.03 | 9193(15.34) | 88.55 | 103.81 |
| 2014 | 13293(22.79) | 157.00 | 84.67 | 20316(34.83) | 250.86 | 80.98 | 15145(25.97) | 171.97 | 88.07 | 9571(16.41) | 89.23 | 107.26 |
| 2015 | 13053(23.01) | 158.07 | 82.58 | 19999(35.26) | 252.64 | 79.16 | 15022(26.49) | 173.17 | 86.75 | 8644(15.24) | 89.84 | 96.21 |
| 2016 | 11283(21.73) | 158.83 | 71.04 | 18243(35.13) | 253.19 | 72.05 | 14455(27.84) | 174.92 | 82.64 | 7950(15.31) | 90.60 | 87.75 |
| 2017 | 12027(22.71) | 159.58 | 75.37 | 18986(35.84) | 257.27 | 73.80 | 13992(26.42) | 174.62 | 80.13 | 7962(15.03) | 90.73 | 87.75 |
| 2018 | 12088(21.75) | 159.70 | 75.69 | 19289(34.70) | 260.85 | 73.95 | 15671(28.19) | 174.16 | 89.98 | 8537(15.36) | 91.30 | 93.51 |
| 2019 | 12188(21.53) | 160.38 | 75.99 | 19847(35.05) | 263.43 | 75.34 | 15656(27.65) | 174.41 | 89.77 | 8929(15.77) | 91.67 | 97.40 |
| 2020 | 11397(21.69) | 159.63 | 71.39 | 18657(35.51) | 265.48 | 70.28 | 14397(27.40) | 175.01 | 82.26 | 8088(15.39) | 91.71 | 88.19 |
| 2021 | 10213(20.74) | 141.83 | 72.01 | 17903(36.35) | 270.67 | 66.14 | 14019(28.46) | 166.02 | 84.44 | 7115(14.45) | 85.93 | 82.80 |
| 2022 | 8950(20.36) | 141.10 | 63.43 | 16051(36.51) | 270.48 | 59.34 | 12482(28.39) | 165.26 | 75.53 | 6484(14.75) | 85.36 | 75.96 |
| 2023 | 9628(21.51) | 140.26 | 68.65 | 17193(38.41) | 271.74 | 63.27 | 11649(26.03) | 163.59 | 71.21 | 6290(14.05) | 84.86 | 74.12 |
| 合计 | 180873(22.09) | 2305.11 | 78.47 | 292749(35.75) | 3823.22 | 76.57 | 220336(26.90) | 2559.12 | 86.10 | 125000(15.26) | 1329.28 | 94.04 |
| 地区 | 不同时段 | 2009—2023年AAPC (%,95%CI) | P值 | ||
|---|---|---|---|---|---|
| 时间段 | APC(%,95%CI) | P值 | |||
| 湘北地区 | 2009—2023年 | -2.12(-2.72~-1.51) | <0.001 | -2.12(-2.72~-1.51) | <0.001 |
| 湘中地区 | 2009—2023年 | -2.76(-3.36~-2.15) | <0.001 | -2.76(-3.36~-2.15) | <0.001 |
| 湘南地区 | 2009—2021年 | -0.91(-2.27~5.86) | 0.218 | -1.93(-2.85~-0.63) | 0.004 |
| 2021—2023年 | -7.81(-14.54~-0.92) | 0.002 | |||
| 湘西地区 | 2009—2019年 | -1.50(-2.34~3.98) | 0.175 | -2.62(-3.48~-1.62) | <0.001 |
| 2019—2023年 | -5.36(-12.51~-2.56) | <0.001 | |||
| 年份 | 人口数 (×10万) | 病原学阳性 | 病原学阴性 | 无病原学结果 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 患者数[例 (构成比,%)] | 粗发病率 (/10万) | 标化率 (/10万) | 患者数[例 (构成比,%)] | 粗发病率 (/10万) | 标化率 (/10万) | 患者数[例 (构成比,%)] | 发病率 (/10万) | 标化率 (/10万) | ||
| 2009 | 638.48 | 27160(45.01) | 42.54 | 43.37 | 25969(43.03) | 40.67 | 41.62 | 7219(11.96) | 11.31 | 11.77 |
| 2010 | 640.60 | 25287(43.73) | 39.47 | 39.85 | 27623(47.77) | 43.12 | 43.69 | 4911(8.49) | 7.67 | 7.93 |
| 2011 | 656.84 | 25905(44.80) | 39.44 | 39.37 | 27736(47.96) | 42.23 | 42.21 | 4189(7.24) | 6.38 | 6.42 |
| 2012 | 659.56 | 26616(43.85) | 40.35 | 39.52 | 29935(49.31) | 45.39 | 44.65 | 4153(6.84) | 6.30 | 6.09 |
| 2013 | 663.89 | 23699(39.54) | 35.70 | 35.20 | 32352(53.98) | 48.73 | 48.31 | 3887(6.49) | 5.85 | 5.70 |
| 2014 | 669.06 | 22080(37.86) | 33.00 | 32.03 | 32752(56.15) | 48.95 | 47.99 | 3494(5.99) | 5.22 | 5.01 |
| 2015 | 673.72 | 20653(36.41) | 30.65 | 29.60 | 33197(58.53) | 49.27 | 48.04 | 2868(5.06) | 4.26 | 4.06 |
| 2016 | 677.54 | 17962(34.59) | 26.51 | 25.19 | 31326(60.32) | 46.24 | 44.65 | 2643(5.09) | 3.90 | 3.65 |
| 2017 | 682.20 | 18848(35.58) | 27.63 | 26.18 | 31706(59.86) | 46.48 | 45.35 | 2413(4.56) | 3.54 | 3.35 |
| 2018 | 686.01 | 19828(35.67) | 28.90 | 27.09 | 32847(59.09) | 47.88 | 46.74 | 2911(5.24) | 4.24 | 4.01 |
| 2019 | 689.88 | 25740(45.46) | 37.31 | 34.12 | 27893(49.26) | 40.43 | 38.82 | 2987(5.28) | 4.33 | 4.10 |
| 2020 | 691.84 | 27433(52.21) | 39.65 | 35.76 | 22501(42.83) | 32.52 | 31.37 | 2605(4.96) | 3.77 | 3.50 |
| 2021 | 664.45 | 27245(55.32) | 41.00 | 35.52 | 19475(39.54) | 29.31 | 27.50 | 2530(5.14) | 3.81 | 3.36 |
| 2022 | 662.20 | 25387(57.74) | 38.34 | 31.87 | 16952(38.56) | 25.60 | 23.03 | 1628(3.70) | 2.46 | 2.03 |
| 2023 | 660.45 | 27949(62.44) | 42.32 | 34.13 | 15785(35.27) | 23.90 | 20.64 | 1026(2.29) | 1.55 | 1.32 |
| 合计 | 10016.72 | 361792(44.16) | 36.12 | 33.92 | 408049(49.80) | 40.74 | 39.64 | 49464(6.04) | 4.94 | 4.82 |
| 类别 | 不同时间段 | 2009—2023年AAPC (%,95%CI) | P值 | ||
|---|---|---|---|---|---|
| 时间段 | APC(%,95%CI) | P值 | |||
| 病原学阳性 | 2009—2017年 | -6.83(-9.20~-5.20) | 0.009 | -2.20(-3.22~-1.39) | <0.001 |
| 2017—2020年 | 12.30(-3.07~16.42) | 0.062 | |||
| 2020—2023年 | -3.07(-12.35~3.38) | 0.145 | |||
| 病原学阴性 | 2009—2014年 | 2.97(0.90~9.22) | 0.015 | -5.07(-5.77~-4.33) | <0.001 |
| 2014—2018年 | -1.60(-17.20~0.59) | 0.129 | |||
| 2018—2023年 | -14.97(-18.06~-11.45) | <0.001 | |||
| 无病原学结果 | 2009—2011年 | -23.27(-30.54~-10.40) | <0.001 | -14.35(-16.06~-12.65) | <0.001 |
| 2011—2016年 | -10.57(-16.05~0.24) | 0.054 | |||
| 2016—2021年 | -1.51(-5.48~7.33) | 0.773 | |||
| 2021—2023年 | -39.47(-48.72~-27.91) | <0.001 | |||
| [1] | World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization, 2025. |
| [2] | Deng LL, Zhao F, Li ZW, et al. Epidemiological characteristics of tuberculosis incidence and its macro-influence factors in Chinese mainland during 2014—2021. Infect Dis Poverty, 2024, 13(1):34. doi:10.1186/s40249-024-01203-6. |
| [3] | Mao Q, Zeng C, Zheng D, et al. Analysis on spatial-temporal distribution characteristics of smear positive pulmonary tuberculosis in China, 2004—2015. Int J Infect Dis, 2019, 80S: S36-S44. doi:10.1016/j.ijid.2019.02.038. |
| [4] |
Dong Z, Yao HY, Yu SC, et al. Changes in Notified Incidence of Pulmonary Tuberculosis in China, 2005—2020. Biomed Environ SCI, 2023, 36(2):117-126. doi:10.3967/bes2023.015.
pmid: 36861190 |
| [5] | 范江静, 龚德华, 万燕萍, 等. 2017—2021年湖南省肺结核流行特征分析. 实用预防医学, 2024, 31(1):13-16. doi:10.3969/j.issn.1006-3110.2024.01.004. |
| [6] | Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000, 19(3):335-351. doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. |
| [7] | 国家统计局. 第七次全国人口普查主要数据情况[EB/OL] [2025-11-12]. https://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202105/t20210511_1817195.html. |
| [8] | 湖南省人民政府. 湖南省14个市州区域划分[EB/OL]. [2025-12-01]. https://hunan.gov.cn/topic/2020hnjksc/jkscwzewm/202012/t20201221_14052031.html. |
| [9] | 国家卫生健康委办公厅. 关于调整肺结核传染病报告分类的通知[EB/OL]. [2025-11-12]. https://www.nhc.gov.cn/jkj/c100063/201903/d9a9d668ab394554a56f8adf51b0926c.shtml. |
| [10] | World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024. |
| [11] | 宋媛媛, 李涛, 夏辉, 等. 1997—2023年全国肺结核报告发病流行病学特征. 中国防痨杂志, 2024, 46(10):1198-1208. doi:10.19982/j.issn.1000-6621.20240382. |
| [12] | 丁远路, 肖文静, 陶芳芳, 等. 基于Joinpoint回归模型的2009—2023年上海市肺结核报告发病趋势分析. 中国防痨杂志, 2025, 47(10):1289-1299. doi:10.19982/j.issn.1000-6621.20250123. |
| [13] | 张苏蕾, 龚德华, 万燕萍, 等. 2019—2022年湖南省遏制结核病行动计划实施效果分析. 实用预防医学, 2025, 32(3):302-305. doi:10.3969/j.issn.1006-3110.2025.03.009. |
| [14] | Zhang G, Yu Y, Zhang W, et al. Influence of COVID-19 for delaying the diagnosis and treatment of pulmonary tuberculosis-Tianjin, China. Front Public Health, 2022, 10:937844. doi:10.3389/fpubh.2022.937844. |
| [15] | 龚亚波, 刘礼亲, 徐祖辉, 等. 新型冠状病毒感染疫情对湖南省结核病定点医院医疗服务的影响研究. 结核与肺部疾病杂志, 2023, 4(4):277-282. doi:10.19983/j.issn.2096-8493.20230068. |
| [16] | 刘礼亲, 明辉, 徐祖辉. 新型冠状病毒感染疫情对湖南省结核病预防控制机构工作的影响研究. 结核与肺部疾病杂志, 2023, 4(3):229-234. doi:10.19983/j.issn.2096-8493.20230051. |
| [17] |
Rickman HM, Phiri MD, Feasey H, et al. Sex differences in the risk of Mycobacterium tuberculosis infection: a systematic review and meta-analysis of population-based immunoreactivity surveys. Lancet Public Health, 2025, 10(7): e588-e598. doi:10.1016/S2468-2667(25)00120-3.
pmid: 40602858 |
| [18] | Guerra-Silveira F, Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS One, 2013, 8(4): e62390. doi:10.1371/journal.pone.0062390. |
| [19] | Horton KC, MacPherson P, Houben RM, et al. Sex Diffe-rences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. PLoS Med, 2016, 13(9): e1002119. doi:10.1371/journal.pmed.1002119. |
| [20] |
Cheng J, Sun YN, Zhang CY, et al. InCIdence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty, 2020, 9(1):13. doi:10.1186/s40249-019-0614-9.
pmid: 32005290 |
| [21] |
Piergallini TJ, Turner J. Tuberculosis in the elderly: Why inflammation matters. Exp Gerontol, 2018, 105:32-39. doi:10.1016/j.exger.2017.12.021.
pmid: 29287772 |
| [22] | 李婷, 刘双, 王丹霞, 等. 2007—2021年四川省儿童肺结核登记情况及流行病学特征分析. 疾病监测, 2024, 39(9):1115-1121. doi:10.3784/jbjc.202310070526. |
| [23] | 梁麟龙, 裴异, 周海依, 等. 2014—2023年湖南省0-14岁儿童肺结核流行特征及变化趋势. 中国防痨杂志, 2025, 47(1):29-35. doi:10.19982/j.issn.1000-6621.20240341. |
| [24] | 魏靖入, 陈卉, 成君. 高中学生肺结核筛查和预防性治疗研究进展. 结核与肺部疾病杂志, 2024, 5(4):358-363. doi:10.19983/j.issn.2096-8493.2024072. |
| [25] | 明辉, 唐益, 肖涛, 等. 湖南省不同职业、年龄肺结核患者流行特征及重点人群防控策略分析. 赣南医学院学报, 2019, 39(9):914-919. doi:10.3969/j.issn.1001-5779.2019.09.013. |
| [26] | Basu RR, Whittaker E, Seddon JA, et al. Tuberculosis susceptibility and protection in children. Lancet Infect Dis, 2019, 19(3): e96-e108. doi:10.1016/S1473-3099(18)30157-9. |
| [27] |
Newton SM, Brent AJ, Anderson S, et al. Paediatric tuberculosis. Lancet Infect Dis, 2008, 8(8):498-510. doi:10.1016/S1473-3099(08)70182-8.
pmid: 18652996 |
| [28] |
Gilmour B, Xu Z, Bai L, et al. The impact of ethnic minority status on tuberculosis diagnosis and treatment delays in Hunan Province, China. BMC Infect Dis, 2022, 22(1):90. doi:10.1186/s12879-022-07072-4.
pmid: 35081919 |
| [29] | 陈可, 虞浩, 竺丽梅, 等. 江苏省2011—2021年病原学阳性肺结核时空分布特征分析. 中华流行病学杂志, 2024, 45(4):513-519. doi:10.3760/cma.j.cn112338-20230915-00161. |
| [30] | 梁爽, 蒋轶文, 杨桂玲, 等. 辽宁省2016—2022年病原学阳性肺结核流行特征及治疗转归分析. 中国热带医学, 2023, 23(11):1127-1133. doi:10.13604/j.cnki.46-1064/r.2023.11.01. |
| [31] | 赵琰枫, 屠霞, 王嫩寒, 等. 三种检测方法在肺结核患者病原学阳性检出中的贡献分析. 中国防痨杂志, 2025, 47(6):701-707. doi:10.19982/j.issn.1000-6621.20250005. |
| [32] | Huang G, Xu Z, Bai L, et al. Spatiotemporal analysis of tuberculosis in the Hunan Province, China, 2014—2022. Front Public Health, 2024, 12:1426503. doi:10.3389/fpubh.2024.1426503. |
| [1] | Liu Xi, Liu Yuze, Hua Weiyu, Li Jie, Zhang Ying, Dong Bin. Epidemiological characteristics of pulmonary tuberculosis among residents in Haidian District,Beijing from 2012 to 2022 and its correlation with population density [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 459-467. |
| [2] | Shangguan Shichao, Wang Ke, Wang Liansen, Duan Xi, Huang Pengxiang, Yao Mingxiao, Lou Lei. The epidemic trend of pulmonary tuberculosis in Shandong Province from 2005 to 2023 [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 64-72. |
| [3] | Ding Yuanlu, Xiao Wenjing, Tao Fangfang, Feng Wei, Wang Ye, Rao Lixin, Shen Xin, Chen Jian, Chen Jing. Analysis of reported incidence trends of pulmonary tuberculosis in Shanghai, China, 2009—2023, using a Joinpoint regression model [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1289-1299. |
| [4] | Teng Chong, Wang Yulan, Liu Liu, Zhang Fang, Huang Fei, Li Tao, Zhao Bing, Zhao Yanlin, Ou Xichao. Analysis of the epidemiological characteristics and prediction for the reported incidence of pulmonary tuberculosis in Dongcheng District, Beijing from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 397-402. |
| [5] | You Enqing, Li Juan, Chen Lili, Liu Wei, Wu Jinju, Cao Hong. Influence of meteorological factors on the incidence of pulmonary tuberculosis in Hefei City from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 349-356. |
| [6] | Song Yuanyuan, Li Tao, Xia Hui, Zhang Lijie, Zhang Hui, Zhao Yanlin, Wang Lixia. Analysis of the epidemiological characteristics of national reported pulmonary tuberculosis incidence, 1997—2023 [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1198-1208. |
| [7] | Du Yongcheng, Lin Shufang, Dai Zhisong, Lin Jian. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Fujian Province from 2008 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1219-1226. |
| [8] | He Yijun, Cheng Jun, Gao Lei. Epidemiological investigation of latent tuberculosis infection should be carried out systematically [J]. Chinese Journal of Antituberculosis, 2024, 46(1): 1-7. |
| [9] | Mao Hongkai, Zhang Yan, Liang Zhichao, Xia Wenjun, Bao Liangliang, Mayisha·Daken , Wang Xiaomin, Cao Mingqin. Evaluation of implementation effect of pulmonary tuberculosis prevention and control strategy in southern Xinjiang based on synthetic control method [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 383-390. |
| [10] | Liu Simin, Li Qiaomei, Tang Jiayi, Li Tingting, Ding Guowu. Analysis of trend in tuberculosis incidence among people aged 0-10 years in China based on an age-period-cohort model [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 181-187. |
| [11] | Du Yongcheng, Lin Shufang, Chen Daiquan, Chen Jiangfen, Dai Zhisong. Analysis of reported incidence of pulmonary tuberculosis and cross-regional medical care seeking among students in Fujian Province from 2005 to 2021 [J]. Chinese Journal of Antituberculosis, 2023, 45(10): 974-980. |
| [12] | Chen Hui, Zhang Canyou, Zhang Hui, Cheng Jun, Li Tao. Analysis on the epidemic situation of pulmonary tuberculosis in schools in China from 2004 to 2021 [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 768-776. |
| [13] | Li Ting, Liu Shuang, Lu Jia, Wang Danxia, Xia Lan. Analysis on the trend of age change of pulmonary tuberculosis in Sichuan from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 808-814. |
| [14] | KANG Wan-li, LI Tian-jing, WANG Sai-sai, LI Chang-hua, ZHAO Qiu-yue, ZHENG Su-hua, LIU Yang. Study on the trend and prediction of reported incidence of national active pulmonary tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 681-684. |
| [15] | Zhang Xin, Lang Shengli, Bai Guohui, Gao Yulong, Xu Lijuan. Surveillance and analysis of tuberculosis in Inner Mongolia from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1256-1261. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.